I-131 Tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: Radiation dose to the testes

被引：0
|
作者：
Hattori, Naoya [1 ]
Gopal, Ajay [1 ]
Fisher, Darrell [2 ]
Durack, Lawrence [1 ]
Shields, Andrew [1 ]
Press, Oliver [1 ]
Rajendran, Joseph [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Pacific Northwest Natl Lab, Richland, WA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1836
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Essential Role of Nuclear Medicine Technology in Tositumomab and I-131-Tositumomab Therapeutic Regimen for Non-Hodgkin's Lymphoma
    Cole, William C.
    Barrickman, Jennifer
    Bloodworth, Glen
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2006, 34 (02) : 67 - 73
  • [22] Low-dose hyper-radiosensitivity model for 131I radioimmunotherapy of non-Hodgkin's lymphoma
    Roberson, Peter
    Wilderman, Scott
    Avram, Anca
    Kaminski, Mark
    Dewaraja, Yuni
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [23] Radioimmunotherapy of non-Hodgkin's lymphoma
    Britton, KE
    JOURNAL OF NUCLEAR MEDICINE, 2004, 45 (05) : 924 - 925
  • [24] Radioimmunotherapy for non-Hodgkin's lymphoma
    Friedberg, JW
    CLINICAL CANCER RESEARCH, 2004, 10 (23) : 7789 - 7791
  • [25] Safety of 131I-Rituximab Outpatient Radioimmunotherapy of Non-Hodgkin Lymphoma
    Calais, P. J.
    Turner, J. H.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [26] Radioimmunotherapy for Non-Hodgkin's Lymphoma
    Rao, Arati V.
    Akabani, Gamal
    Rizzieri, David A.
    CLINICAL MEDICINE & RESEARCH, 2005, 3 (03) : 157 - 165
  • [27] Radioimmunotherapy for non-Hodgkin's lymphoma
    Emmanouilides, C
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 531 - 544
  • [28] Radioimmunotherapy for non-Hodgkin's lymphoma: A review for radiation oncologists
    Macklis, Roger M.
    Pohlman, Brad
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : 833 - 841
  • [29] Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab
    Elstrom, Rebecca L.
    Ruan, Jia
    Christos, Paul J.
    Martin, Peter
    Lebovic, Daniel
    Osborne, Joseph
    Goldsmith, Stanley
    Greenberg, June
    Furman, Richard R.
    Avram, Anca
    Putman, Ryan
    Chapman, Erica
    Mazumdar, Madhu
    Griffith, Kent
    Coleman, Morton
    Leonard, John P.
    Kaminski, Mark S.
    LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 342 - 346
  • [30] Clinical experience of Weill Cornell Medical Center with 131I-tositumomab (Bexxar™) radioimmunotherapy in relapsed/refractory non-Hodgkin's lymphoma (NHL).
    Kostakoglu, L
    Leonard, JP
    Coleman, M
    Vallabhajosula, S
    Kroll, S
    Fiore, JM
    Scarano, D
    Hack, S
    Goldsmith, SJ
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 312P - 312P
12345